Angiogenesis in autosomal-dominant polycystic kidney disease

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 62, Pages S12-S22 (December 2002)
Volume 70, Issue 1, Pages (July 2006)
Mihaela Skobe, Michael Detmar 
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 57, Issue 2, Pages (October 2000)
Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis  April E. Nedeau, MD,
Osteopontin expression in human crescentic glomerulonephritis
Volume 68, Issue 2, Pages (August 2005)
Volume 68, Issue 6, Pages (December 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 56, Issue 4, Pages (October 1999)
Volume 56, Issue 1, Pages (July 1999)
Volume 54, Issue 1, Pages (July 1998)
VEGF Gene Delivery to Muscle
Volume 74, Issue 7, Pages (October 2008)
Volume 71, Issue 3, Pages (February 2007)
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Volume 57, Issue 4, Pages (April 2000)
Volume 58, Issue 3, Pages (September 2000)
Volume 67, Issue 5, Pages (May 2005)
Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: A corrosion cast study  W. Wei, V. Popov,
Karen M. Newman, PhD, Jessie Jean-Claude, MD, Hong Li, MS, John V
Volume 53, Issue 4, Pages (April 1998)
Volume 60, Issue 2, Pages (August 2001)
Volume 54, Issue 6, Pages (January 1998)
Volume 61, Issue 5, Pages (May 2002)
Volume 62, Issue 6, Pages (December 2002)
Volume 58, Issue 4, Pages (October 2000)
Volume 80, Issue 2, Pages (July 2011)
Ralph Witzgall, Bettina Kränzlin, Norbert Gretz, Nicholas Obermüller 
Kameswaran Surendran, Theodore C. Simon, Helen Liapis, John K. McGuire 
Volume 60, Issue 4, Pages (October 2001)
Kimberly A. Muczynski, Tom Cotner, Susan K. Anderson 
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 77, Issue 9, Pages (May 2010)
Volume 68, Issue 4, Pages (October 2005)
Volume 58, Issue 2, Pages (August 2000)
Volume 68, Issue 6, Pages (December 2005)
Atubular glomeruli in a rat model of polycystic kidney disease
Volume 70, Issue 1, Pages (July 2006)
Decorin, biglycan and their endocytosis receptor in rat renal cortex
Volume 80, Issue 2, Pages (July 2011)
Volume 61, Issue 6, Pages (June 2002)
Lymphatic vessels develop during tubulointerstitial fibrosis
Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: A corrosion cast study  W. Wei, V. Popov,
Volume 57, Issue 3, Pages (March 2000)
Volume 63, Issue 4, Pages (April 2003)
Volume 68, Issue 4, Pages (October 2005)
Volume 61, Issue 6, Pages (June 2002)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 59, Issue 3, Pages (March 2001)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Volume 62, Pages S12-S22 (December 2002)
Volume 63, Issue 1, Pages (January 2003)
Recruitment of renal tubular epithelial cells expressing verotoxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal disease  Xue-Hui Liu, Clifford.
Volume 62, Issue 2, Pages (August 2002)
Volume 57, Issue 6, Pages (June 2000)
Volume 57, Issue 1, Pages (January 2000)
Volume 80, Issue 5, Pages (September 2011)
Volume 53, Issue 4, Pages (April 1998)
Increased importin α protein expression in diabetic nephropathy
Volume 69, Issue 10, Pages (May 2006)
Volume 72, Issue 11, Pages (December 2007)
Volume 58, Issue 6, Pages (December 2000)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 56, Issue 4, Pages (October 1999)
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

Angiogenesis in autosomal-dominant polycystic kidney disease Elsa Bello-Reuss, M.D., Keith Holubec, Srinivasan Rajaraman  Kidney International  Volume 60, Issue 1, Pages 37-45 (July 2001) DOI: 10.1046/j.1523-1755.2001.00768.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 (A) Radiopaque medium angiogram in a ADPKD kidney perfused in vitro (4°C, with preservation solution at 1000 mL/h) 15 (left panel), 30 (center panel), and 60 seconds (right panel) after bolus injection of 50mL of Hypaque 60™ in the upper pole renal artery. (Left panel) Note the stretching and displacement of large vessels. (Central panel) Note the vascularization around the cysts and filling of aneurysmatic dilatations (arrows). (Right panel) Note the tuft-like vessels with peripherally broader branches, rather than the normal tapering (arrows). (B) Fluorescent angiogram of the surface of the same kidney (perfused as described for A) injected with 1mL of Fluorescein® shows vascularization around the cysts, abnormal vessels, and filling of lacunar spaces. Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Vascular network in the wall of ADPKD cysts. (Insert) Freshly mounted cyst wall without staining observed in an inverted Nikon microscope (×200). Note the capillaries and small vessels containing red cells. (A) Microscopic examination of ADPKD kidney sections stained for factor VIII-related antigen. The cyst walls are composed of fibrovascular connective tissue. There are numerous of capillaries of variable caliber, some of them assuming angiomatous configurations resembling cavernous angiomata (arrows, Nikon ×100). (B) Interstitial area demonstrating dilated vessels in a “corkscrew” pattern. Nikon ×200. (C) Microcirculation beneath a renal cyst shows the “corkscrew” characteristic vasculature seen also in interstitial areas (Nikon ×40). (D) Factor VIII-related antigen staining demonstrating ingrowth of vasculature into the lamina propria of the intraluminal papilliferous projections of the cyst epithelium (Nikon ×400). Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 (A) Immunohistochemistry for VEGF is positive in the epithelial cyst cells (brown color, Nikon, ×400). (B) Negative control (Nikon, ×400). Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Immunostaining for VEGF, VEGFR-2, and VEGFR-1 (left, central, and right upper panels, respectively) in areas of relatively preserved morphology. Glomeruli and remnant tubules are recognized. (Upper left) Staining for VEGF seen in some tubule cells (arrow). (Center) Staining for VEGFR-2 seen in interstitial areas with increased matrix, at high power corresponding to vasculature (short arrow, at the right), in some cells of the remnant glomerulus cells (long arrow) and in remnant tubule cells (narrow, short arrow at the left). (Right) Staining for VEGFR-1 seen in remnant tubule cells (arrow). No staining of interstitial structures or of the glomerulus (in the right upper corner) is seen. Lower panels are the negative controls. Left for VEGF, center for VEGFR-2, and right for VEGFR-1 (Nikon, ×100). Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Immunostaining demonstrates the expression of VEGFR-2 (KDR) in small vessels in the interstitium of a cyst. The narrow cyst epithelial cells (arrow at the top) do not express VEGFR-2 (Nikon ×400). Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 (A) Determination of VEGF165 expression by Western blot analysis with the specific monoclonal antibody VEGFab-4. Lane 1, control recombinant VEGF165. Lane 2, protein from human proximal tubule cells in culture (HPT). Lanes 3, 5, and 6, protein from three different ADPKD cyst cell cultures: PKD(1), PKD(2), and PKD(3). Lane 4, protein from MCF-7 cells (a human cancer cell line). (B) VEGF165 in pg/mg protein in the conditioned medium of ADPKD cyst cells cultured in 20% or 5% O2 for 8 or 72 hours (Methods section). The release of VEGF165 increased after incubation in low oxygen for 72 hours. Symbols are: (□) ADPKD, 20% O2 for 8 hours; (▪) ADPKD, 5% O2 for 8 hours; () ADPKD, 20% O2 for 72 hours; () ADPKD 5% O2 for 72 hours; () MCF/7, 20% O2 for 8 hours; () MCF/7, 5% O2 for 8 hours. *P = 0.014, N = 6. Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 (A and B) Immunofluorescence photomicrographs of pericystic interstitial capillaries stained with FITC-anti-integrin αvβ3 antibody (green). (C and D) RITC-anti-MMP-2 immunostaining (red). (E and F) Colocalization of FITC-anti-integrin αvβ3 and anti-MMP-2 antibodies (yellow), indicating the coexpression in the lining of endothelial cells. (G and H) The corresponding fields to A and B (sections are serial, a few micrometers away) identifying the capillaries with antibody directed against Factor VIII-related antigen. Kidney International 2001 60, 37-45DOI: (10.1046/j.1523-1755.2001.00768.x) Copyright © 2001 International Society of Nephrology Terms and Conditions